Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2013 Filed Feb 20, 2013 22:35 UTC |
LINDER GREG WDirector
|
GrantOption (right to buy) · Derivative | 106,600 | $0.00 Strike: $34.94 | $0.00 |
DisclosureSEC source: 0001179110-13-003142 · edgar.xml · derivative · entry 5 LINDER GREG W · CIK 0001239128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,600 Underlying: Common shares · 106,600 shares Expires 2023-02-14 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 35,534 on 2/15/2014, 35,533 on 2/15/2015, and 35,533 on 2/15/2016. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 22:35 UTC |
LINDER GREG WDirector
|
GrantCommon shares without par value | 20,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003142 · edgar.xml · nonDerivative · entry 1 LINDER GREG W · CIK 0001239128 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,889 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:17 UTC |
Forrest A. DavidSenior Vice President
|
GrantOption (right to buy) · Derivative | 165,000 | $0.00 Strike: $34.94 | $0.00 |
DisclosureSEC source: 0001179110-13-003167 · edgar.xml · derivative · entry 2 Forrest A. David · CIK 0001501589 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,000 Underlying: Common shares · 165,000 shares Expires 2023-02-14 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 55,000 on 2/15/2014, 55,000 on 2/15/2015, and 55,000 on 2/15/2016. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:18 UTC |
Mason Heather LSenior Vice President
|
GrantOption (right to buy) · Derivative | 119,700 | $0.00 Strike: $34.94 | $0.00 |
DisclosureSEC source: 0001179110-13-003168 · edgar.xml · derivative · entry 4 Mason Heather L · CIK 0001432601 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,700 Underlying: Common shares · 119,700 shares Expires 2023-02-14 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 39,900 on 2/15/2014, 39,900 on 2/15/2015, and 39,900 on 2/15/2016. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:18 UTC |
Mason Heather LSenior Vice President
|
GrantCommon shares without par value | 23,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003168 · edgar.xml · nonDerivative · entry 1 Mason Heather L · CIK 0001432601 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,808 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:18 UTC |
Simhambhatla Murthy VSenior Vice President
|
GrantOption (right to buy) · Derivative | 119,700 | $0.00 Strike: $34.94 | $0.00 |
DisclosureSEC source: 0001179110-13-003169 · edgar.xml · derivative · entry 6 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,700 Underlying: Common shares · 119,700 shares Expires 2023-02-14 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 39,900 on 2/15/2014, 39,900 on 2/15/2015, and 39,900 on 2/15/2016. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:18 UTC |
Simhambhatla Murthy VSenior Vice President
|
GrantCommon shares without par value | 23,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003169 · edgar.xml · nonDerivative · entry 1 Simhambhatla Murthy V · CIK 0001566034 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,569 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:19 UTC |
Warmuth Michael JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 149,600 | $0.00 Strike: $34.94 | $0.00 |
DisclosureSEC source: 0001179110-13-003170 · edgar.xml · derivative · entry 4 Warmuth Michael J · CIK 0001452290 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,600 Underlying: Common shares · 149,600 shares Expires 2023-02-14 F1 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 49,867 on 2/15/2014, 49,866 on 2/15/2015, and 49,867 on 2/15/2016. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:20 UTC |
White J. ScottSenior Vice President
|
GrantOption (right to buy) · Derivative | 133,500 | $0.00 Strike: $34.94 | $0.00 |
DisclosureSEC source: 0001179110-13-003171 · edgar.xml · derivative · entry 3 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,500 Underlying: Common shares · 133,500 shares Expires 2023-02-14 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 44,500 on 2/15/2014, 44,500 on 2/15/2015, and 44,500 on 2/15/2016. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:20 UTC |
White J. ScottSenior Vice President
|
GrantCommon shares without par value | 25,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003171 · edgar.xml · nonDerivative · entry 1 White J. Scott · CIK 0001479543 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,366 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:20 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 980,000 | $0.00 Strike: $34.94 | $0.00 |
DisclosureSEC source: 0001179110-13-003172 · edgar.xml · derivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 980,000 Underlying: Common shares · 980,000 shares Expires 2023-02-14 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 326,667 on 2/15/2014, 326,666 on 2/15/2015, and 326,667 on 2/15/2016. Read SEC document |
| February 15, 2013 Filed Feb 20, 2013 23:20 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantCommon shares without par value | 210,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-13-003172 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479,570 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 22:56 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 9,690 | $0.00 Strike: $31.90 | $0.00 |
DisclosureSEC source: 0001179110-13-001810 · edgar.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 9,690 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 22:56 UTC |
Fussell Stephen RSenior Vice President
|
SaleCommon shares without par value | 9,690 | $33.89 | $328,394.10 |
DisclosureSEC source: 0001179110-13-001810 · edgar.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,093 Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 22:56 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 9,690 | $31.90 | $309,122.63 |
DisclosureSEC source: 0001179110-13-001810 · edgar.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,783 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 22:55 UTC |
OSBORN WILLIAM ADirector
|
PurchaseCommon shares without par value | 650 | $33.86 | $22,009.00 |
DisclosureSEC source: 0001179110-13-001807 · edgar.xml · nonDerivative · entry 6 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,476 Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 22:55 UTC |
OSBORN WILLIAM ADirector
|
PurchaseCommon shares without par value | 4,400 | $33.87 | $149,028.00 |
DisclosureSEC source: 0001179110-13-001807 · edgar.xml · nonDerivative · entry 5 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,826 Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 22:55 UTC |
OSBORN WILLIAM ADirector
|
PurchaseCommon shares without par value | 1,300 | $33.88 | $44,037.50 |
DisclosureSEC source: 0001179110-13-001807 · edgar.xml · nonDerivative · entry 4 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,426 Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 22:55 UTC |
OSBORN WILLIAM ADirector
|
PurchaseCommon shares without par value | 100 | $33.83 | $3,383.25 |
DisclosureSEC source: 0001179110-13-001807 · edgar.xml · nonDerivative · entry 3 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,126 Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 22:55 UTC |
OSBORN WILLIAM ADirector
|
PurchaseCommon shares without par value | 2,750 | $33.83 | $93,032.50 |
DisclosureSEC source: 0001179110-13-001807 · edgar.xml · nonDerivative · entry 2 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,026 Read SEC document |
| February 01, 2013 Filed Feb 4, 2013 22:55 UTC |
OSBORN WILLIAM ADirector
|
PurchaseCommon shares without par value | 800 | $33.84 | $27,068.00 |
DisclosureSEC source: 0001179110-13-001807 · edgar.xml · nonDerivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,276 Read SEC document |
| January 14, 2013 Filed Jan 16, 2013 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GrantOption (right to buy) · Derivative | 300,401 | $0.00 Strike: $33.37 | $0.00 |
DisclosureSEC source: 0001179110-13-000925 · edgar.xml · derivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,401 Underlying: Common shares · 300,401 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 14, 2013 Filed Jan 16, 2013 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionOption (right to buy) · Derivative | 346,704 | $0.00 Strike: $25.76 | $0.00 |
DisclosureSEC source: 0001179110-13-000925 · edgar.xml · derivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 346,704 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 14, 2013 Filed Jan 16, 2013 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Tax withholdingCommon shares without par value | 300,401 | $33.37 | $10,024,381.37 |
DisclosureSEC source: 0001179110-13-000925 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,269,570 Read SEC document |
| January 14, 2013 Filed Jan 16, 2013 22:04 UTC |
WHITE MILES DDirector · Chairman and CEO
|
Exercise / conversionCommon shares without par value | 346,704 | $25.76 | $8,929,534.87 |
DisclosureSEC source: 0001179110-13-000925 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,569,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2012 Filed Jan 3, 2013 22:14 UTC |
LIDDY EDWARD MDirector
|
GrantStock Equivalent Units · Derivative | 503 | $65.50 Strike: $0.00 | $32,946.50 |
DisclosureSEC source: 0001179110-13-000229 · edgar.xml · derivative · entry 1 LIDDY EDWARD M · CIK 0001188983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,878 Underlying: Common shares · 503 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2012 Filed Jan 3, 2013 22:15 UTC |
TILTON GLENN FDirector
|
GrantStock Equivalent Units · Derivative | 503 | $65.50 Strike: $0.00 | $32,946.50 |
DisclosureSEC source: 0001179110-13-000231 · edgar.xml · derivative · entry 1 TILTON GLENN F · CIK 0001194624 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,460 Underlying: Common shares · 503 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2012 Filed Jan 3, 2013 22:15 UTC |
OSBORN WILLIAM ADirector
|
GrantStock Equivalent Units · Derivative | 526 | $65.50 Strike: $0.00 | $34,453.00 |
DisclosureSEC source: 0001179110-13-000232 · edgar.xml · derivative · entry 1 OSBORN WILLIAM A · CIK 0001171797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,331 Underlying: Common shares · 526 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2012 Filed Jan 3, 2013 22:15 UTC |
Alpern Robert JDirector
|
GrantStock Equivalent Units · Derivative | 120 | $65.50 Strike: $0.00 | $7,860.00 |
DisclosureSEC source: 0001179110-13-000233 · edgar.xml · derivative · entry 1 Alpern Robert J · CIK 0001448074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,423 Underlying: Common shares · 120 shares Expires not disclosed F1 · derivative.exercise_price: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 20, 2012 Filed Dec 28, 2012 22:05 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-018332 · edgar.xml · nonDerivative · entry 9 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 7,202 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 20, 2012 Filed Dec 28, 2012 22:05 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 183 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-018332 · edgar.xml · nonDerivative · entry 7 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 0 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 20, 2012 Filed Dec 28, 2012 22:05 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 183 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-018332 · edgar.xml · nonDerivative · entry 3 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,223,267 Read SEC document |
| December 17, 2012 Filed Dec 28, 2012 22:05 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 385 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-018332 · edgar.xml · nonDerivative · entry 2 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,223,450 Read SEC document |
| December 14, 2012 Filed Dec 28, 2012 22:05 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-018332 · edgar.xml · nonDerivative · entry 8 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By son Disclosed balance after: 7,293 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 14, 2012 Filed Dec 28, 2012 22:05 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 366 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-018332 · edgar.xml · nonDerivative · entry 6 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 183 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 14, 2012 Filed Dec 28, 2012 22:05 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 549 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-018332 · edgar.xml · nonDerivative · entry 5 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 549 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and sons. Read SEC document |
| December 14, 2012 Filed Dec 28, 2012 22:05 UTC |
WHITE MILES DDirector · Chairman and CEO
|
GiftCommon shares without par value | 15,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-018332 · edgar.xml · nonDerivative · entry 1 WHITE MILES D · CIK 0001239129 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,223,835 Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 11,500 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · derivative · entry 13 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,333 Underlying: Common shares · 11,500 shares Expires 2021-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 652 | $0.00 Strike: $59.01 | $0.00 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · derivative · entry 12 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 652 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,395 | $0.00 Strike: $52.74 | $0.00 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · derivative · entry 11 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 2,395 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 1,045 | $0.00 Strike: $58.16 | $0.00 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · derivative · entry 10 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,045 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 67,200 | $0.00 Strike: $52.54 | $0.00 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · derivative · entry 9 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 67,200 shares Expires 2017-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 36,985 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · derivative · entry 8 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 36,985 shares Expires 2015-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option granted pursuant to Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon shares without par value | 119,777 | $66.00 | $7,905,282.00 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · nonDerivative · entry 7 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,338 Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 11,500 | $46.60 | $535,900.00 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · nonDerivative · entry 6 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 299,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 652 | $59.01 | $38,474.52 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · nonDerivative · entry 5 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 2,395 | $52.74 | $126,312.30 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 286,963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 1,045 | $58.16 | $60,777.20 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,568 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 67,200 | $52.54 | $3,530,688.00 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2012 Filed Dec 13, 2012 22:14 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 36,985 | $46.34 | $1,713,884.90 |
DisclosureSEC source: 0001179110-12-017513 · edgar.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 216,323 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.